Logo image of ARE

ALEXANDRIA REAL ESTATE EQUIT (ARE) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:ARE - US0152711091 - REIT

48.76 USD
+0.69 (+1.44%)
Last: 12/24/2025, 3:40:00 PM
48.7799 USD
+0.02 (+0.04%)
After Hours: 12/24/2025, 3:40:00 PM

ARE Key Statistics, Chart & Performance

Key Statistics
Market Cap8.43B
Revenue(TTM)3.19B
Net Income(TTM)-421.07M
Shares172.83M
Float170.79M
52 Week High105.14
52 Week Low44.1
Yearly Dividend5.22
Dividend Yield5.88%
EPS(TTM)-2.47
PEN/A
Fwd PE58.34
Earnings (Next)01-26 2026-01-26/amc
IPO1997-05-28
Sector
GICS SectorReal Estate
GICS IndustryDiversified REITs
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS SubIndustryHealth Care REITs


ARE short term performance overview.The bars show the price performance of ARE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

ARE long term performance overview.The bars show the price performance of ARE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ARE is 48.76 USD. In the past month the price decreased by -6.15%. In the past year, price decreased by -51.12%.

ALEXANDRIA REAL ESTATE EQUIT / ARE Daily stock chart

ARE Latest News, Press Relases and Analysis

ARE Competitors/Peers

The largest stocks on the US markets in the "Health Care REITs" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
WELL WELLTOWER INC 129.45 128.82B
VTR VENTAS INC 153.12 37.40B
OHI OMEGA HEALTHCARE INVESTORS 23.8 13.08B
DOC HEALTHPEAK PROPERTIES INC 80.15 11.14B
AHR AMERICAN HEALTHCARE REIT INC 186.15 9.07B
CTRE CARETRUST REIT INC 26.97 8.25B
HR HEALTHCARE REALTY TRUST INC N/A 5.94B
SBRA SABRA HEALTH CARE REIT INC 25.93 4.66B
DHCNL DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 N/A 4.38B
DHCNI DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 N/A 4.06B
NHI NATL HEALTH INVESTORS INC 25.41 3.67B
MPW MEDICAL PROPERTIES TRUST INC N/A 3.04B

About ARE

Company Profile

ARE logo image Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 552 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.

Company Info

ALEXANDRIA REAL ESTATE EQUIT

26 North Euclid Avenue

Pasadena CALIFORNIA 91101 US

CEO: Stephen A. Richardson

Employees: 552

ARE Company Website

ARE Investor Relations

Phone: 16265780777

ALEXANDRIA REAL ESTATE EQUIT / ARE FAQ

What does ARE do?

Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 552 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.


Can you provide the latest stock price for ALEXANDRIA REAL ESTATE EQUIT?

The current stock price of ARE is 48.76 USD. The price increased by 1.44% in the last trading session.


Does ARE stock pay dividends?

ALEXANDRIA REAL ESTATE EQUIT (ARE) has a dividend yield of 5.88%. The yearly dividend amount is currently 5.22.


What is the ChartMill rating of ALEXANDRIA REAL ESTATE EQUIT stock?

ARE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Is ALEXANDRIA REAL ESTATE EQUIT (ARE) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ARE.


Is ALEXANDRIA REAL ESTATE EQUIT (ARE) expected to grow?

The Revenue of ALEXANDRIA REAL ESTATE EQUIT (ARE) is expected to decline by -3.36% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the employee count for ARE stock?

ALEXANDRIA REAL ESTATE EQUIT (ARE) currently has 552 employees.


ARE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ARE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ARE. ARE has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ARE Financial Highlights

Over the last trailing twelve months ARE reported a non-GAAP Earnings per Share(EPS) of -2.47. The EPS decreased by -250.61% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.13%
ROE -2.53%
Debt/Equity 0.82
Chartmill High Growth Momentum
EPS Q2Q%-243.75%
Sales Q2Q%-3.07%
EPS 1Y (TTM)-250.61%
Revenue 1Y (TTM)0.18%

ARE Forecast & Estimates

For the next year, analysts expect an EPS growth of -110.94% and a revenue growth -3.36% for ARE


Analysts
Analysts68.42
Price TargetN/A
EPS Next Y-110.94%
Revenue Next Year-3.36%

ARE Ownership

Ownership
Inst Owners98.03%
Ins Owners1.05%
Short Float %3.66%
Short Ratio2.07